Inherited diseases involving G proteins and G protein-coupled receptors

Annual Review of Medicine

Volumn 55, Issue , 2004, Pages 27-39

  Spiegel, Allen M ^a   Weinstein, Lee S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Gain and loss of function mutations; Hormone resistance; Signal transduction

Indexed keywords

AMINO ACID; DIVALENT CATION; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; HORMONE; MONOAMINE; NUCLEOSIDE;

ALBRIGHT SYNDROME; BODY GROWTH; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; ENDOCRINE DISEASE; GENE LOSS; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENOME IMPRINTING; HORMONE RESISTANCE; HUMAN; INHERITANCE; METABOLIC DISORDER; MOLECULAR EVOLUTION; PARATHYROID DISEASE; PHOTON; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; RETINA DISEASE; REVIEW; SIGNAL TRANSDUCTION; STIMULATION;

GENETIC DISEASES, INBORN; GTP-BINDING PROTEINS; HUMANS; MUTATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 1542358991     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.55.091902.103843     Document Type: Review

References (50)

1. Vassilatis DK, Hohmann JG, Zeng H, et al. 2003. The G protein-coupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. USA 100(8):4903-8
2. Pierce KL, Premont RT, Lefkowitz RJ. 2002. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3:639-50
3. Palczewski K, Kumasaka T, Hori T, et al. 2000. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289: 739-45
4. Bockaert J, Pin JP. 1999. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18:1723-29
5. Seifert R, Wenzel-Seifert K. 2002. Constitutive activity of G-protein coupled receptors: cause of disease and common property of wild-type receptors. Naunyn. Schmiedebergs. Arch. Pharmacol 366:381-416
6. Hamm H. 2001. How activated receptors couple to G proteins. Proc. Natl. Acad. Sci. USA 98:4819-21
7. Dessauer CW, Posner BA, Gilman AG. 1996. Visualizing signal transduction: receptors, G proteins and adenylate cyclases. Clin. Sci. 91:527-37
8. Neer EJ. 1995. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80:249-57
9. Spiegel AM. 1998. G Proteins, Receptors, and Disease. Totawa, NJ: Humana
10. Muradov KG, Artemyev NO. 2000. Loss of the effector function in a transducin-α mutant associated with Nougaret night blindness. J. Biol. Chem. 275:6969-74
11. Lyons J, Landis CA, Harsh G, et al. 1990. Two G protein oncogenes in human endocrine tumors. Science 249:655-59
12. Williamson EA, Johnson SJ, Foster S, et al. 1995. G protein gene mutations in patients with multiple endocrinopathies. J. Clin. Endocrinol. 80:1702-5
13. sα gene GNAS1 in the pathogenesis of acromegaly. J. Clin. Invest. 107:R31-36
14. sα mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J. Clin. Endocrinol. Metab. 79:750-55
15. Weinstein LS, Shenker A, Gejman PV, et al. 1991. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325:1688-95
16. s. J. Pediatr. 123:509-18
17. Mockridge KA, Levine MA, Reed LA, et al. 1999. Polyendocrinopathy, skeletal dysplasia, organomegaly, and distinctive facies associated with a novel, widely expressed Gsα mutation. Am. J. Hum. Genet. 65(Suppl.): A426 (Abstr.)
18. Okamoto S, Hisaoka M, Ushijima M, et al. 2000. Activating Gsα mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Arch. 437:133-37
19. Candeliere GA, Glorieux FH, Prud'homme J, et al. 1995. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N. Engl. J. Med. 332:1546-51
20. Collins MT, Chebli C, Jones J, et al. 2001. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J. Bone Miner. Res. 16:806-13
21. Kim I, Kim ER, Nam HJ, et al. 1999. Activating mutation of Gsa in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Horm. Res. 52:235-40
22. Weinstein LS, Yu S, Warner DR, et al. 2001. Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr. Rev. 22:675-705
23. Spiegel AM, Weinstein LS. 2001. Pseudohypoparathyroidism. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 4205-21. New York: McGraw-Hill
24. Shore EM, Ahn J, Jan de Beur S, et al. 2002. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N. Engl. J. Med. 346:99-106
25. Germain-Lee EL, Ding C-L, Deng Z, et al. 2002. Paternal imprinting of Gas in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem. Biophys. Res. Commun. 296:67-72
26. Iiri T, Herzmark P, Nakamoto JM, et al. 1994. Rapid GDP release from Gs-alpha in patients with gain and loss of endocrine function. Nature 371:164-67
27. Juppner H, Schipani E, Bastepe M, et al. 1998. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc. Natl. Acad. Sci. USA 95:11798-803
28. Liu J, Litman D, Rosenberg MJ, et al. 2000. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J. Clin. Invest. 106:1167-74
29. Bastepe M, Lane AH, Jüppner H. 2001. Paternal uniparental disomy of chromosome 20q-and the resulting changes in GNAS1 methylation as a plausible cause of pseudohypoparathyroidism. Am. J. Hum. Genet. 68:1283-89
30. αs. A cause of pseudohypoparathyroidism type Ib. J. Biol. Chem. 276:165-71
31. Siffert W, Rosskopf D, Siffert G, et al. 1998. Association of a human G-protein β3 subunit variant with hypertension. Nat. Genet. 18:45-48
32. Brand E, Wang JG, Herrmann SM, et al. 2003. An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gβ3 C825T polymorphism. J. Hypertens. 21:729-37
33. Von Beckerath N, Schusterschitz Y, Koch Y, et al. 2003. G protein β3 subunit 825T allele carriage and risk of coronary artery disease. Atherosclerosis 167:135-39
34. Fernandez-Real JM, Penarroja G, Richart C, et al. 2003. G protein β3 gene variant, vascular function, and insulin sensitivity in type 2 diabetes. Hypertension 41:124-29
35. Lee A, Rana BK, Schiffer HH, et al. 2003. Distribution analysis of nonsynonymous polymorphisms within the G-protein-coupled receptor gene family. Genomics 81:245-48
36. 171 Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 88(4):1873-79
37. Jordan N, Williams N, Gregory JW, et al. 2003. The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a caucasian population. J. Clin. Endocrinol. Metab. 88(3):1002-5
38. Corvilain B, Van Sande J, Dumont JE, et al. 2001. Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin. Endocrinol. 55:143-58
39. Carasquillo MM, McCallion AS, Puffenberger EG, et al. 2002. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat. Genet. 32:237-44
40. Themmen AP, Verhoef-Post M. 2002. LH receptor defects. Semin. Reprod. Med. 20(3):199-204
41. Wysolmerski JJ, Cormier S, Philbrick WM, et al. 2001. Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction. J. Clin. Endocrinol. Metab. 86(4):1487-88
42. 2 vasopressin receptors found in patients with nephrogenic diabetes insipidus. J. Clin. Endocrinol. Metab. 87(11):5247-57
43. Hu J, Spiegel AM. 2003. Naturally occurring mutations of the extracellular Ca++-sensing receptor: implications for understanding its structure and function. Trends Endocrinol. Metab. 14:282-88
44. Farooqi S, Keogh JM, Yeo GSH, et al. 2003. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348(12):1085-95
45. Berson EL. 2002. Retinitis pigmentosa and allied diseases. In Principles and Practice of Ophthalmology, ed. DM Albert, FA Jakobiec, DT Azar, ES Gragoudas, pp. 2262-90. Philadelphia: Saunders
46. Calvi LM, Schipani E. 2000. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia. J. Endocrinol. Invest. 23(8):545-54
47. Hopyan S, Gokgoz N, Poon R, et al. 2002. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat. Genet. 30(3):306-10
48. Liu R, Paxton WA, Choe S, et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell 86:367-377
49. 2c-adrenergic receptors and the risk of congestive heart failure. N. Engl. J. Med. 347(15):1135-42
50. Covic L, Misra M, Badar J, et al. 2002. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nat. Med. 8(10):1161-65